OBJECTIVE: The rate of glucose disposal was determined in 10 black and 10 white obese nondiabetic urban women from South Africa to assess insulin resistance. DESIGN AND METHODS: Euglycemic hyperinsulinemic clamp and body composition analysis. RESULTS: Age, body mass index (BMI), anthropometric measurements and body composition were similar in both groups of women. A five-level computed tomography (CT) scan showed a similar mean subcutaneous fat mass in both groups of women (black obese women 555 +/- 9.0 vs white obese women 532 +/- 6.0 cm2), but less visceral fat in black obese women (90 +/- 3.0 vs 121 +/- 3.1 cm2; P< 0.05). Black obese women had higher fasting free fatty acid (997 +/- 69 vs 678 +/- 93 micromol/l; P < 0.05) and lactate concentrations (1,462 +/- 94 vs 1,038 +/- 39 micromol/l; P < 0.05), but lower fasting insulin levels (87 +/- 12 vs 155 +/- 9 pmol/l; P < 0.001). Black obese women also had a more favorable HDL: total cholesterol ratio (30.5% vs 23.0%; P< 0.04). The mean glucose disposal rate (M) and disposal expressed as glucose sensitivity index (M/I) were reduced in the black obese women vs white obese women (M: 7.1 +/- 0.8 vs 13.7 +/- 1.0 mmol/kg min(-1) x 100; P< 0.01, and M/I: 0.12 +/- 0.01 vs 0.24 +/- 0.02 mmol/kg x min(-1)/pmol/1 x 1,000; P < 0.01). Only black obese women showed a significant decrease in C-peptide levels during the clamp (2.9 +/- 0.22 vs 1.2 +/- 0.12 nmol/l; P<0.001). During the euglycemic period, the black obese women had higher lactate levels at all time points, but only the white obese women had increased lactate levels (918 +/- 66 to 1,300 +/- 53 micromol/l; P< 0.05). CONCLUSION: Black obese women demonstrate a higher degree of insulin resistance, despite less visceral fat and a higher HDL: total-cholesterol ratio. In addition, endogenous beta-cell secretory function in black obese women appears to be more sensitive to the suppressive effect of exogenous insulin administration. The significant increase in lactate levels in white obese women confirms that they are more insulin sensitive.
OBJECTIVE: The rate of glucose disposal was determined in 10 black and 10 white obese nondiabetic urbanwomen from South Africa to assess insulin resistance. DESIGN AND METHODS: Euglycemic hyperinsulinemic clamp and body composition analysis. RESULTS: Age, body mass index (BMI), anthropometric measurements and body composition were similar in both groups of women. A five-level computed tomography (CT) scan showed a similar mean subcutaneous fat mass in both groups of women (black obesewomen 555 +/- 9.0 vs white obesewomen 532 +/- 6.0 cm2), but less visceral fat in black obesewomen (90 +/- 3.0 vs 121 +/- 3.1 cm2; P< 0.05). Black obesewomen had higher fasting free fatty acid (997 +/- 69 vs 678 +/- 93 micromol/l; P < 0.05) and lactate concentrations (1,462 +/- 94 vs 1,038 +/- 39 micromol/l; P < 0.05), but lower fasting insulin levels (87 +/- 12 vs 155 +/- 9 pmol/l; P < 0.001). Black obesewomen also had a more favorable HDL: total cholesterol ratio (30.5% vs 23.0%; P< 0.04). The mean glucose disposal rate (M) and disposal expressed as glucose sensitivity index (M/I) were reduced in the black obesewomen vs white obesewomen (M: 7.1 +/- 0.8 vs 13.7 +/- 1.0 mmol/kg min(-1) x 100; P< 0.01, and M/I: 0.12 +/- 0.01 vs 0.24 +/- 0.02 mmol/kg x min(-1)/pmol/1 x 1,000; P < 0.01). Only black obesewomen showed a significant decrease in C-peptide levels during the clamp (2.9 +/- 0.22 vs 1.2 +/- 0.12 nmol/l; P<0.001). During the euglycemic period, the black obesewomen had higher lactate levels at all time points, but only the white obesewomen had increased lactate levels (918 +/- 66 to 1,300 +/- 53 micromol/l; P< 0.05). CONCLUSION: Black obesewomen demonstrate a higher degree of insulin resistance, despite less visceral fat and a higher HDL: total-cholesterol ratio. In addition, endogenous beta-cell secretory function in black obesewomen appears to be more sensitive to the suppressive effect of exogenous insulin administration. The significant increase in lactate levels in white obesewomen confirms that they are more insulin sensitive.
Authors: Cristina Lara-Castro; Erin C Doud; Patrick C Tapia; Andres J Munoz; Jose R Fernandez; Gary R Hunter; Barbara A Gower; W Timothy Garvey Journal: Obesity (Silver Spring) Date: 2008-09-25 Impact factor: 5.002
Authors: Cyndya A Shibao; Jorge E Celedonio; Claudia E Ramirez; Latisha Love-Gregory; Amy C Arnold; Leena Choi; Luis E Okamoto; Alfredo Gamboa; Italo Biaggioni; Naji N Abumrad; Nada A Abumrad Journal: J Clin Endocrinol Metab Date: 2016-05-04 Impact factor: 5.958
Authors: J H Goedecke; E Chorell; D E W Livingstone; R H Stimson; P Hayes; K Adams; J A Dave; H Victor; N S Levitt; S E Kahn; J R Seckl; B R Walker; T Olsson Journal: Int J Obes (Lond) Date: 2014-05-20 Impact factor: 5.095
Authors: Julia H Goedecke; Joel A Dave; Mirjam V Faulenbach; Kristina M Utzschneider; Estelle V Lambert; Sacha West; Malcolm Collins; Tommy Olsson; Brian R Walker; Jonathan R Seckl; Steven E Kahn; Naomi S Levitt Journal: Diabetes Care Date: 2009-02-05 Impact factor: 17.152